Natural Shrimp completes shrimp trial in Japan

The trial compared a tank treated by the patented electrocoagulation and Hydrogas™ with a tank treated by a traditional biofilter.

Credits: Shutterstock
May 1, 2024

Natural Shrimp has completed a six-month trial in Japan with the company's patented Electrocoagulation (EC) and Hydrogas™ technologies.

The trial compared a tank treated by the EC and Hydrogas™ with a tank treated by a traditional biofilter. Throughout the six-month trial, the EC effectively removed the ammonia from the water. In addition, the shrimp growth rate increased during the presence of Hydrogas when compared to the shrimp growth rate in the tank treated only by the biofilter.

The Japanese team performed extensive testing of the equipment that included, among other things, collecting data under varying conditions by testing different flow rates, ammonia levels, and amperage levels. Based on the empirical results demonstrated by the equipment during the trial, Natural Shrimp looks to either joint venture, license or form a business combination in Japan.

Tom Untermeyer, Natural Shrimp chief technology officer said, "I very much enjoyed working with the team in Japan during the installation and operation of our equipment in the Japanese shrimp research facility. The Japanese quickly learned how to operate the EC and Hydrogas equipment and shared with us the data that they collected during the trial. The Japanese market is uniquely set up for the NSI technology based on its current shrimp import conditions and a robust consumption of shrimp as a primary protein source. I am excited to see where this will lead us in the future with the hope of helping them and others develop successful shrimp production systems using our technologies."